CAR T Cells in Mesothelin-Expressing Breast Cancer
Status: RECRUITING
Study type: INTERVENTIONAL
Conditions: Breast Cancer
Interventions: DRUG: huCART-meso cells|DEVICE: Mesothelin Expression Testing
Sponsor: University of Pennsylvania